Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Aprepitant to Improve Same-Day Discharge After Total Knee Arthroplasty
NCT07639723Phase 4Not yet recruiting
- Sponsor
- Endeavor Health
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Endeavor Health. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07639723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07639723.